Roles of increased glycemic variability, glucagon-like-1 peptide (GLP-1) and glucagon in hypoglycaemia after Roux-en-Y gastric bypass
European Journal of Endocrinology Sep 08, 2017
Tharakan G, et al. - Researchers performed a cohort study which indicated that an early peak in glucagon-like-1 peptide (GLP-1) and glucagon, due to post-operative L-cell hypertrophy and aberrant processing of proglucagon, may trigger an exaggerated insulinotropic response to eating in patients with postprandial hypoglycemia (PPH).
Methods
Go to Original
- Researchers examined a cohort of PPH patients at the Imperial Weight Center.
- They conducted continuous glucose monitoring to define their altered glycemic variability.
- They further carried out a mixed meal test (MMT) and measured gut hormone concentrations.
- They observed increased glycemic variability in the cohort of PPH patients, specifically a higher Mean Amplitude Glucose Excursion (MAGE) score of 4.9.
- They also illustrated significantly greater and earlier increases in insulin and GLP-1 concentration in patients who had hypoglycemia in response to an MMT (MMT Hypo) relative to those that did not (MMT Non-Hypo).
- A significantly increased glucagon secretion was observed in the MMT Hypo group versus the Non-hypo group.
- There were no significant differences in oxyntomodulin, GIP or peptide YY secretion between these two groups.
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries